Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 6 Issue 11

The Monkeypox Review 2022: Transmission of A Zoonotic Disease Over the World Including India

Surabhi Gupta1*, Jay Kumar2, Abhishek Kumar Singh2, Sharda Shakya3, Reema Yadav2, Ruchi Verma2 and Vandana Yadav2

1M. Pharm (Medicinal and Pharmaceutical Chemistry), Assistant Professor, Sakshi College of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University (AKTU), Lucknow (U.P), India
2Department of Pharmacy, Research Scholar, School of Pharmaceutical Sciences (Formerly University Institute of Pharmacy), Kanpur (U.P) and Chhatrapati Shahu Ji Maharaj University, Kanpur (U.P), India
3Department of Pharmacy, Research Scholar, Advance Institute of Biotech and Paramedical Sciences, Dr. A.P.J. Abdul Kalam Technical University (AKTU), Lucknow (U.P), India

*Corresponding Author: Surabhi Gupta, M. Pharm (Medicinal and Pharmaceutical Chemistry), Assistant Professor, Sakshi College of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University (AKTU), Lucknow (U.P), India.

Received: October 13, 2022; Published: October 31, 2022


Background: Since May 2022, it was determined that monkeypox, a viral disease, was still on the rise. The first case was discovered on May 6, 2022, in a person with travel ties to Nigeria, and the initial group of cases was confirmed there. This review article provides an updated overview of monkeypox for healthcare and medical experts around the world. The existing 2022 monkeypox outbreak spanning multiple nations is the biggest healthcare problem outside of Africa in recorded history. On July 14, 2022, a 35-year-old man traveling from the U.A.E was diagnosed with monkeypox in Kerala, India, becoming the first episode of the disease in the WHO region of South-East Asia. A new A.2 strain has been found in 2 cases in India that had returned from the UAE that is different from the strain causing the worrying outbreak of Monkeypox cases in Europe. In 2003, the first case of monkeypox had been officially identified outside Africa in the American West.

Objective: The main aim of this article is to create meaningful data on monkeypox cases around the world including India during the 2022 pandemic.

Method: Online survey of the records of the patients has been performed through various websites.

Result: The data of the monkeypox infected patients has been collected from India as well as from the entire world.

Conclusion: In the current scenario monkeypox outbreak is the biggest issue outside of Africa in recorded history, but the data obtained from India to date shows that monkeypox became stable.

Keywords: Monkeypox; A.2 Strain; Endemic; Poxvirus; Blister


  1. Girometti, Nicolò., et al. "Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis”. The Lancet Infectious Diseases9 (2022): 1321-1328.
  2. Gong Qizan., et al. "Monkeypox virus: a re-emergent threat to humans”. Virologica Sinica (2022).
  3. Yinka-Ogunleye Adesola., et al. "Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report”. The Lancet Infectious Diseases8 (2019): 872-879.
  4. Alakunle Emmanuel., et al. "Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution”. Viruses11 (2020): 1257.
  5. Ladnyj ID., et al. "A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo”. Bulletin of the World Health Organization5 (1972): 593.
  6. Magnus Preben von., et al. "A pox‐like disease in cynomolgus monkeys”. Acta Pathologica Microbiologica Scandinavica2 (1959): 156-176.
  7. Jezek Z., et al. "Human monkeypox”. Journal of Hygiene, Epidemiology, Microbiology, and Immunology1 (1983): 13-28.
  8. Sejvar James J., et al. "Human monkeypox infection: a family cluster in the midwestern United States”. The Journal of Infectious Diseases10 (2004): 1833-1840.
  9. Foster Stanley O., et al. "Human monkeypox”. Bulletin of the World Health Organization5 (1972): 569.
  10. Xuan Do Thi Minh., et al. "Comparison of Transcriptomic Signatures between Monkeypox-Infected Monkey and Human Cell Lines”. Journal of Immunology Research2022 (2022).
  11. Youssef Dalal., et al. "When a neglected tropical zoonotic disease emerges in non-endemic countries: Need to proactively fill the unveiled knowledge gaps towards human monkeypox among the Lebanese population”. (2022).
  12. World Health Organization (WHO). Monkeypox fact sheet. Geneva: WHO; (2022).
  13. Kaler Jasndeep., et al. "Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation”. Cureus7 (2022).
  14. Gomes Juliana Assis Silva., et al. "Immune modulation in primary vaccinia virus zoonotic human infections”. Clinical and Developmental Immunology2012 (2012).
  15. International Committee on Taxonomy of Viruses (ICTV) (2020).
  16. Formenty Pierre., et al. "Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005”. Emerging infectious diseases10 (2010): 1539.
  17. Adebayo O and D Owoeye. "1. Department of Medicine, University College Hospital, Ibadan, Nigeria 2. Infection Prevention and Control Directorate, Jazan, Kingdom of Saudi Arabia”. Annals of Ibadan Postgraduate Medicine2 (2017): 145.
  18. Centers for Disease Control and Prevention. Monkeypox.
  19. Damon Inger K. "Status of human monkeypox: clinical disease, epidemiology and research”. Vaccine29 (2011): D54-D59.
  20. Fuller Trevon., et al. "Using remote sensing to map the risk of human monkeypox virus in the Congo Basin”. EcoHealth1 (2011): 14-25.
  21. Hutin Y J., et al. "Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997”. Emerging Infectious Diseases3 (2001): 434.
  23. Parker Scott., et al. "Human monkeypox: an emerging zoonotic disease”. (2007): 17-34.
  24. Hutson Christina L., et al. "Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak”. The American Journal of Tropical Medicine and Hygiene4 (2007): 757-768.
  25. Vaughan Aisling., et al. "Human-to-human transmission of monkeypox virus, United Kingdom, October 2018”. Emerging Infectious Diseases4 (2020): 782.
  26. World Health Organization (WHO). “Monkeypox” (2022).
  27. Li Daniel., et al. "Evaluation of the GeneXpert for human monkeypox diagnosis”. The American Journal of Tropical Medicine and Hygiene2 (2017): 405.
  28. WHO, European CDC, US CDC, and Ministries of Health Monkeypox Outbreak Global Map. 2022 U.S. Map and Case Count | Monkeypox | Poxvirus | CDC.
  29. Guarner Jeannette., et al. "Monkeypox in 2022—what clinicians need to know”. Jama2 (2022): 139-140.
  30. Bunge Eveline M., et al. "The changing epidemiology of human monkeypox—A potential threat? A systematic review”. PLoS Neglected Tropical Diseases2 (2022): e0010141.
  31. World Health Organization. Monkeypox—United Kingdom of Great Britain and Northern Ireland (2022).
  32. Centers for disease control and Prevention.
  33. World Health Organization. Monkeypox (2019).
  34. Petersen Brett W., et al. "Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses—recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015”. Morbidity and Mortality Weekly Report10 (2016): 257-262.
  35. Collister Kristen and Sam S Dahr. "Frosted branch angiitis after smallpox vaccination”. American Journal of Ophthalmology Case Reports27 (2022): 101622.
  36. Greenberg Richard N and Jeffrey S Kennedy. "ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine”. Expert Opinion on Investigational Drugs4 (2008): 555-564.
  37. JYNNEOSTMPackage Insert .World Health Organization. Monkeypox (2019).
  38. Ullah Asad., et al. "An integrative reverse vaccinology, immunoinformatic, docking and simulation approaches towards designing of multi-epitopes based vaccine against monkeypox virus”. Journal of Biomolecular Structure and Dynamics (2022): 1-14.


Citation: Surabhi Gupta., et al. “The Monkeypox Review 2022: Transmission of A Zoonotic Disease Over the World Including India". Acta Scientific Pharmaceutical Sciences 6.11 (2022): 31-42.


Copyright: © 2022 Surabhi Gupta., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US